PINK1 and cancer: Dysregulation of pre-mRNA processing involving key ATG genes is linked to cancer progression [61–64], whereas splice mutations in genes such as PINK1 and PRKN are associated with Alzheimer’s and Parkinson’s diseases [65–68].